Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Frostbite Sequelae
NCT06460194Phase 2Withdrawn
- Sponsor
- University Hospital of North Norway
- Start
- Nov 2022
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in frostbite, sponsored by University Hospital of North Norway. Planned start Nov 2022; status: withdrawn.
02
Drugs
botulinum toxin type A
03
Conditions
frostbite
Beyond the preview
Go deeper on NCT06460194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06460194.